CCL17 and Alzheimer disease: In this study, the DNCB-only group exhibited a significant increase in the expression of IL4, IL13, IL31, TSLP, TARC/CCL17, MDC/CCL22, IFN-γ, IL1β, and TNF-α, all of which are consistently expressed with AD.